X

Diagnostics

Vijaya Diagnostic Q3FY23 net profit drops by 35 percent

Vijaya Diagnostic reported total income of INR 116.67 crores during the period ended December 31, 2022 as compared to INR…

Earnings Summary Of Fortis Healthcare Limited For Q3 FY23

Fortis Healthcare Limited (NSE: FORTIS) is one of India's leading healthcare providers, offering a range of medical services across its…

Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year

Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the…

Thyrocare Technologies net profit declines by 43% in the December 2022 quarter

Net profit of Thyrocare Technologies declined by 43.47% to INR 13 crore in the quarter ended December 2022 as against…

Dr Lal PathLabs Ltd Q3 FY23 Earnings Conference Call Insights

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked…

Vijaya Diagnostic: A King in the Making

“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to…

Krsnaa Diagnostics Ltd (KRSNAA) Q2 FY23 Earnings Concall Transcript

Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Yash Prithviraj Mutha C.A. -- Whole-Time…

Dr Lal PathLabs Ltd Q2 FY23 Earnings Conference Call Insights

https://youtu.be/lAaNZKEvjOc Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred…

Earnings Infographic: Dr. Lal PathLabs Q1 2023 revenue and profit decline

Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and…

Dr Lal PathLabs Limited Research Report

Stock Data Ticker: LALPATHLAB Exchange :     NSE BSE:         539524 Industry:      Diagnostic Price Performance Last 7 days             8.70% YTD                     -38.28% Last…